PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
31865175-1	2020	The isocitrate dehydrogenase (IDH1/2) mutations are frequent genetic abnormalities in the majority of WHO grade II/III glioma and secondary GBM.	Isocitrates	4-14	isocitrate dehydrogenase 1 (NADP+), soluble	Mus musculus	30-36	
32071674-1	2020	Inhibitors of mutant isocitrate dehydrogenase (mIDH) 1 and 2 cancer-associated enzymes prevent the accumulation of the oncometabolite d-2-hydroxyglutarate (2-HG) and are under clinical investigation for the treatment of several cancers harboring an IDH mutation.	Isocitrates	21-31	isocitrate dehydrogenase 1 (NADP+), soluble	Mus musculus	48-51